🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Meet us next week at iPSC-Derived Cell Therapies Summit, from December 6th to 7th in Boston ! Feel free to connect with our Boston team, CTO Kévin Alessandri and BD Officer Anthony Renodon, based in LabCentral (MassBio). #Boston #celltherapyforall

TreeFrog Therapeutics team will start 2023 in #SanFrancisco ! Frédéric Desdouits and Kévin Alessandri will attend the J.P. Morgan 41st annual Healthcare Meeting from January 9th to 12th 2023. Feel free to reach out to schedule a meeting. #JPMorgan #celltherapyforall

What to find on our new scientific blog ? #1 Exclusive & free resources: a list of #CellTherapy #trials based on #Pluripotent #StemCells, a white paper on the lumenized rosette – the specific 3D conformation adopted by hPSCs in vivo, interviews... treefrog.fr/stemcelljungle/

3/6 Gaia Biomedicine & TreeFrog Therapeutics announce collaboration for the expansion of allogeneic NK-like cells against solid tumors. treefrog.fr/gaia-biomedici…

It's great to see some of our #startups in the new #FT120 & #Next40 rankings! Kudos to @LeCollectionist TreeFrog Therapeutics Skello Ledger @applydia 360Learning 🤩👏

TreeFrog dans le #FT120 ! Quelle trajectoire ? Quels jalons à venir ? Quel impact en France ? 2 min avec Jean-Luc TREILLOU, co-fondateur de TreeFrog Therapeutics. Bienvenue aux nouveaux entrants dans le FrenchTech120, et un grand merci à La French Tech !

Releasing a #whitepaper on the lumenized rosette - the 3D conformation adopted by human #PluripotentStemCells in vivo ! Properties / PSC growth & quality / comparison with 2D/aggregates / Biomimetic PSC culture in large-scale bioreactors Download : treefrog.fr/stemcelljungle…

What can the human body 🧍 teach us about how to scale up high-quality #pluripotent stem cells (PSCs)? Join us for a live webinar on March 7, with Dr. Maxime Feyeux (Maxime Feyeux), co-founder of TreeFrog Therapeutics (TreeFrog Therapeutics), to find out. bit.ly/3YVjMiw

Releasing a pretty exhaustive list of cell therapy trials based on iPS & ES cells! Access for free and share! treefrog.fr/stemcelljungle… Paul Knoepfler Alliance for Regenerative Medicine (ARM) ISSCR ISCT STEMCELL Technologies New York Stem Cell Foundation Research Institute 日本再生医療学会 LINK-J GAiT ESC & iPSC News

Happening live TOMORROW! ⚠️ This is your last chance to sign for this webinar on #pluripotent stem cells with Dr. Maxime Feyeux (Maxime Feyeux): bit.ly/3YVjMiw

New publication demonstrating almost 300-fold #hiPSC expansion in 10L #bioreactors within 1 week with #CStem biomimetic platform with high reproducibility & preservation of cell quality. treefrog.fr/exponential-hi… ISSCR ISCT FSSCR 日本再生医療学会 ESGCT Alliance for Regenerative Medicine (ARM)

Following our recent paper describing #hiPSC #ScaleUp in #10L #bioreactors, our CSO highlights how the C-Stem™ platform can impact the manufacturing of stem cell-derived therapies. More videos answering frequently asked questions about C-Stem™ : treefrog.fr/stemcelljungle/

The TreeFrog Therapeutics alginate encapsulation system efficiency could be due to its ability to recapitulate in capsulo a 3D lumenized colony that morphologically resembles an epiblast rosette, and which has higher cell viability than 2D colonies. sciencedirect.com/science/articl…

TreeFrog Therapeutics' co-founder and CSO Maxime Feyeux will give a talk on scale-up at 日本再生医療学会 meeting (March 24). Do not hesitate to connect with him on-site or during his 2-week trip through Tokyo, Kyoto, Kobe, Osaka and Fukuoka, from March 20th to April 1st. #celltherapyforall

TreeFrog Therapeutics will be in #California next week ! Immuno-oncology Scientist Hélène CABANAS will attend the #InnateKillerSummit 2023, from March 28th to 30th. Do not hesitate to connect with her! #celltherapyforall

After the largest, longest ph 3 of any CAR-T #celltherapy, Kite, a Gilead Company's Yescarta is the 1st treatment in nearly 30 yrs to show stat significant improvement in OS for initial treatment of relapsed/refractory large B-cell lymphoma versus historical SOC. europeanpharmaceuticalreview.com/news/180811/ki…

Our #CSO Maxime Feyeux gives a snapshot of #pluripotent #stemcell #differentiation with the C-Stem™ platform. You can check the other videos answering frequently asked questions about C-Stem™ for #iPS #expansion & #differentiation here: treefrog.fr/stemcelljungle…

"Scaling-up iPSC-based cell therapies: towards clinical grade processes with biomimetic C-Stem technology" Next Wednesday, don't miss Senior Application Scientist Odette Becheau oral presentation at the BELSACT Scientific Meeting in #Leuven. Do not hesitate to connect with her!